MongoDB's AI-ready platform and accelerating enterprise adoption make it a compelling rival to Oracle's legacy-heavy growth.

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.

Who needs rewrites? This metadata-powered architecture fuses AI and ETL so smoothly, it turns pipelines into self-evolving ...

In the new age of data centers, DCIM (Data Center Infrastructure Management) systems must evolve to offer a proactive, ...

Poor data governance can lead to a myriad of issues that include data interpretation inconsistencies, security ...

Recent updates to Bronkhorst’s FLEXI-FLOW Compact series of mass flow controllers and meters have extended their capability ...

Snowflake Inc. (NYSE: SNOW) is experiencing strong growth due to financial success, product innovations, and strategic ...

Kiro’s structured, agentic workflow challenges the Copilot model, offering a spec-first IDE with hooks, task orchestration, ...

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak ...

Discover why MSCI Inc.'s strong ESG growth, robust revenue model, and strategic advantages make it a compelling long-term ...

In an era where artificial intelligence, autonomous vehicles, and high-performance computing push the boundaries of ...

"Multiturn agents never follow a single script, so your tests can't either," explained Atin Sanyal, CTO and Co-founder of Galileo. "Luna-2's session metrics capture conversation quality, intent ...